Dark

Check out our API

FLHLF
FILAMENT HEALTH CORP
stock OTC

Inactive

Jun 9, 2025

0.0200USD+0.756%(+0.0002)32,901

Pre-market

0.00USD-100.000%(-0.02)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 31, 2022

07:06PM EST Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants Benzinga

Jan 10, 2022

08:53AM EST Psyched: Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects, Psilocybin Bill Washington Benzinga

Nov 8, 2021

10:52AM EST Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval Benzinga

Nov 2, 2021

11:40AM EDT Psychedelic Stock Filament Health Jumps On Announcing First Psilocin Clinical Trial Benzinga

07:53AM EDT Filament :FDA Authorizaes Clinical Trial With Direct Psilocin Administration And Psychedelic Botanical Drug Candidates RTTNews

Oct 18, 2021

01:37PM EDT Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation Benzinga

08:36AM EDT KCSA Psychedelics Virtual Investor Conference Presentations Available for PR Newswire

Oct 13, 2021

04:25PM EDT There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are Benzinga

08:35AM EDT Filament Health to Webcast Live at VirtualInvestorConferences.com October 14th PR Newswire

Sep 20, 2021

08:35AM EDT Life Sciences Investor Forum today announced that the presentations from the September 16th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. GlobeNewswire Inc

Sep 10, 2021

08:35AM EDT Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors, and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry. GlobeNewswire Inc

Share